An Ever Growing Portfolio of Diverse Healthcare Companies

Develops comprehensive system to assess platelet functions

Operates medical adult day care centers that are an alternative to nursing home or institutional care

Provides software, services, information and connectivity solutions to enable healthcare providers to deliver best-in-class patient safety, clinical outcomes and financial results

Enables employers to control costs with a benefits strategy that provides employees with a choice of competing health plans, provider networks, benefit products, plan designs and price points

Delivers targeted care management which navigates advanced chronic conditions by providing at-home telemonitoring and home visits to support the most vulnerable patients.

Engineers and develops therapeutic protease products

Emerging biopharmaceutical company which develops novel products to address unmet medical needs

Identifies novel anti-cancer agents that combine the efficacy of cytotoxics with the tumor cell selectivity of modern targeted therapeutics.

Develops innovative cardiovascular products

Develops complete human genome sequencing and analysis

Develops products to address the need for surgical sealing and post-surgical adhesion prevention applications

Develops innovative therapeutics targeting cancer network disruption

Develops the DeBakey ventricular assist device as bridge to heart transplant

Develops needle-free, wireless, transdermal continuous glucose monitoring system

Develops antibody-based therapies to treat infectious diseases.

Develops innovative device technology and treatment to address th eunmet needs of ENT physicians and their patients

Provides reports and ratings to guide patients to better care providers

Manages radiology utlization with payer organization

Focuses on rapid development of prescription drugs for mild to moderate pain relief

Develops minimally-invasive hearing products

Rapidly identifies human DNA

Provides financial solutions to health care facilities, including purchase of receivables and lien solutions programs

Develops a novel, non-invasive technology for the treatment of hypertension (HTN)

Develops and markets biologic products for the repair or replacement of damaged or inadequate tissues.